DexCom Inc (DXCM) is a Healthcare · Medical Devices company listed on NASDAQ. Price $89.67 (+1.98%), Market cap $27.57B, P/E ratio 28.69, 52-week low–high $54.84 ~ $89.53.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabet
Financial statements, price targets, institutional (13F) holdings and related news for DexCom Inc are updated in real time on BlackAll Trade.
DexCom Inc trades at $89.67 (+1.98%). Real-time quotes and charts are available on BlackAll Trade.
DexCom Inc has a market cap of about $27.57B. Its P/E ratio is 28.69.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in